Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
Sarah Cannon Research Institute
ClinicalTrials.gov Identifier:
NCT01014351
First received: November 16, 2009
Last updated: March 20, 2013
Last verified: December 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2013
  Estimated Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)